Abbott Laboratories

NYSE: ABT
$116.80
-$0.93 (-0.8%)
Closing Price on November 6, 2024

ABT Articles

U.S. equity markets opened lower this morning following a downturn in Europe and mixed markets in Asia. Data releases were limited everywhere today as well. In Asia, a weaker yen boosted the Nikkei,...
ThinkstockAbbott Laboratories (NYSE: ABT) reported first-quarter 2013 results before markets opened this morning. The drugmaker reported adjusted diluted earnings per share (EPS) of $0.42 on revenues...
Jon OggInvestors and traders are looking for new ideas as the markets challenge new all-time highs to generate income and profits. 24/7 Wall St. reviews many analyst calls and research notes to find...
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
U.S. equity markets opened higher this morning following a string of solid earnings reports yesterday and after markets closed last night. As we note below, earnings results were more mixed today,...
U.S. equity markets opened about flat this morning following the holiday weekend in the U.S. Foreign markets were also more or less mixed. In Europe, the German and eurozone economic indexes came in...
The Merrill Lynch research team at Bank of America Corporation (NYSE: BAC) is out with its key RIC report for 2013, which is titled “2013: Back to the Future” for the start of 2013. There are...
courtesy of NetflixChina’s services index rises to 56.1 in December, a sign of healthy expansion. (Reuters) Apple Inc. (NASDAQ: AAPL) tests a new iPhone and iOS 7. (Reuters) A court rejects an...
Frank Golhen, via Wikimedia CommonsU.K. Nears Recession Add the United Kingdom to the long line of countries that have gotten into more economic trouble that expected. The Office for National...
U.S. equity markets opened flat to higher again this morning following the third revision to U.S. GDP growth in the third quarter and the report on new claims for unemployment benefits (more coverage...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Thursday. Abbott Laboratories (NYSE: ABT) started as Outperform at William Blair....
ThinkstockDrug developer Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) watched its shares plummet 35% yesterday following a report that rheumatoid arthritis treatment it was developing with AstraZeneca...
ThinkstockOn December 7, marijuana became legal in the state of Washington, adding to the list of states that have moved toward legalizing or decriminalizing the drug. Will this be a national trend...
As corporate earnings are disappointing and as the economy remains very sluggish, companies are announcing big waves of layoffs. Some have said that the layoffs this time of year are seasonal, as...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations we have seen from Wall St. research calls this Friday. Abbott Laboratories (NYSE: ABT) raised to Outperform at Wells...